← back to search

Youngho Seo

University of California, San Francisco · US
Area of research
Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine
Research interest
Research interests include Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Medical Imaging Techniques and Applications, and Multiple Myeloma Research and Treatments.
h-index
46
citations
8,283
works
724
NIH funding
primary concept
email

Recent publications

Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy
Clinical Cancer Research 2025cited by 9position: middledoi
1072 Noninvasive detection of immunotherapy-related cardiac effects using [ <sup>1</sup> <sup>8</sup> F]F-AraG PET
Regular and Young Investigator Award Abstracts 2025cited by 0position: middledoi
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
Science Translational Medicine 2024cited by 89position: middledoi
<sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with<sup>18</sup>F-FDG
Journal of Nuclear Medicine 2024cited by 32position: middledoi
Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5
Theranostics 2024cited by 27position: middledoi
PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer
Molecular Cancer Therapeutics 2024cited by 13position: middledoi
[18F]F-AraG imaging reveals association between neuroinflammation and brown- and bone marrow adipose tissue
Communications Biology 2024cited by 7position: middledoi
Organ-specific fuel rewiring in acute and chronic hypoxia redistributes glucose and fatty acid metabolism
Cell Metabolism 2023cited by 70position: middledoi
Covalent Proteins as Targeted Radionuclide Therapies Enhance Antitumor Effects
ACS Central Science 2023cited by 56position: middledoi
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
Clinical Cancer Research 2023cited by 47position: middledoi
CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment
Journal of Experimental & Clinical Cancer Research 2023cited by 39position: middledoi
Evaluation of<sup>134</sup>Ce/<sup>134</sup>La as a PET Imaging Theranostic Pair for<sup>225</sup>Ac α-Radiotherapeutics
Journal of Nuclear Medicine 2023cited by 35position: middledoi
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma
Clinical Cancer Research 2023cited by 26position: middledoi
First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody
Nature Communications 2022cited by 48position: middledoi
Imaging joint infections using D-methyl-11C-methionine PET/MRI: initial experience in humans
European Journal of Nuclear Medicine and Molecular Imaging 2022cited by 31position: middledoi
Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system
Scientific Reports 2022cited by 31position: middledoi
Biodistribution of a Mitochondrial Metabolic Tracer, [ <sup>18</sup> F]F-AraG, in Healthy Volunteers
Molecular Imaging 2022cited by 19position: middledoi
Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons
Nature Communications 2021cited by 168position: middledoi
Direct Attenuation Correction Using Deep Learning for Cardiac SPECT: A Feasibility Study
Journal of Nuclear Medicine 2021cited by 57position: lastdoi
Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies
Journal of Nuclear Medicine 2020cited by 55position: middledoi
<sup>124</sup>I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma
Journal of Nuclear Medicine 2020cited by 52position: lastdoi
Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET
Clinical Cancer Research 2020cited by 40position: middledoi
An Open-Source, Vender Agnostic Hardware and Software Pipeline for Integration of Artificial Intelligence in Radiology Workflow
Journal of Digital Imaging 2020cited by 39position: middledoi
Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy
International Journal of Radiation Oncology*Biology*Physics 2020cited by 31position: middledoi
Domain specific word embeddings for natural language processing in radiology
Journal of Biomedical Informatics 2020cited by 28position: middledoi
Maximizing the use of batch production of 18F-FDOPA for imaging of brain tumors to increase availability of hybrid PET/MR imaging in clinical setting
Neuro-Oncology Practice 2020cited by 6position: middledoi
Quantitative Imaging of Alpha-Emitting Therapeutic Radiopharmaceuticals
Nuclear Medicine and Molecular Imaging 2019cited by 47position: firstdoi
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using <sup>18</sup>F-FDG PET of the Brain
Radiology 2018cited by 568position: middledoi
Iterative PET Image Reconstruction Using Convolutional Neural Network Representation
IEEE Transactions on Medical Imaging 2018cited by 270position: middledoi
Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis
npj Breast Cancer 2018cited by 111position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Henry F. VanBrocklin · University of California, San Francisco13 papers (2016–2025)Robert R. Flavell · University of California, San Francisco12 papers (2018–2025)Jiang He · Beijing Zhenxing Metrology & Measurement Institute7 papers (2020–2025)Anil P. Bidkar · University of California, San Francisco7 papers (2023–2025)Kondapa Naidu Bobba · University of California, San Francisco7 papers (2023–2025)David M. Wilson · University of California, San Francisco7 papers (2022–2025)Rahul Aggarwal · UCSF Helen Diller Family Comprehensive Cancer Center6 papers (2020–2025)Joseph Blecha · University of California, San Francisco6 papers (2016–2025)Anju Wadhwa · University of California, San Francisco6 papers (2023–2025)Scott Bidlingmaier · University of California, San Francisco6 papers (2023–2025)Niranjan Meher · National Institute of Pharmaceutical Education and Research6 papers (2023–2025)Jaewon Yang · The University of Texas Southwestern Medical Center6 papers (2016–2021)Miguel Hernandez Pampaloni · University of California, San Francisco5 papers (2014–2021)Jonathan Chou · UCSF Helen Diller Family Comprehensive Cancer Center5 papers (2020–2025)Bin Liu · University of California, San Francisco5 papers (2023–2025)Randall A. Hawkins · University of California, San Francisco4 papers (2014–2020)Shih-Ying Huang · National Chung Hsing University4 papers (2014–2020)Suchi Dhrona · University of California, San Francisco4 papers (2023–2024)Emily Chan · Chulalongkorn University4 papers (2023–2024)Thomas A. Hope · UCSF Helen Diller Family Comprehensive Cancer Center4 papers (2017–2024)